Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial | Diabetes | JAMA | JAMA Network
aThree participants who wore CGM for less than 70% of the time during the 10-day prerandomization screening phase (≥70% was eligibility criterion) were randomized: 2 to the CGM group and 1 to the BGM group. bOne participant in each group was missing baseline data. cOne participant randomized to the CGM group who was determined after randomization to have type 1 diabetes was excluded from the analyses (participant had HbA1c level of 8.2% at baseline, 7.3% at month 3, and 6.8% at month 8). BGM indicates blood glucose meter; and CGM, continuous glucose monitoring. A, In this scatterplot, points below the diagonal line represent cases in which the 8-month HbA1c level was lower than the baseline level (80 [76%] in the CGM group vs 34 [67%] in the BGM group) and points above the diagonal line represent cases in which the 8-month HbA1c level was higher than the baseline level (23 [22%] in the CGM group vs 14 [27%] in the BGM group). Two participants in the CGM group and 3 in the BGM group had
Explore this link on the map →